CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis Management of Asymptomatic Severe Aortic Stenosis: Evolving Concepts in Timing of Valve Replacement A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement Comparison of Early Surgical or Transcatheter Aortic Valve Replacement Versus Conservative Management in Low-Flow, Low-Gradient Aortic Stenosis Using Inverse Probability of Treatment Weighting: Results From the TOPAS Prospective Observational Cohort Study Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement Balloon Aortic Valvuloplasty as a Bridge to Aortic Valve Replacement: A Contemporary Nationwide Perspective A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry Expansion or contraction of stenting in coronary artery disease?

Original Research

JOURNAL:CBSMD Article Link

紫杉醇涂层球囊的最新研究进展

CBSMD

Pre-reading

支架内再狭窄仍是个临床难题,紫杉醇涂层球囊(Paclitaxel-coated balloons,PCBs)不失为一种替代方案。以下为PCBs的最新研究证据:


2019年1月新鲜出炉的Clinical and angiographic outcomes of coronary dissection after paclitaxel-coated balloon angioplasty for small vessel coronary artery disease纳入了单中心 2.8mm的小冠脉血管病变,试图解释PCB即可经造影明确的冠脉夹层的发生机制及分型,并开展了术后长于6个月的临床随访,以进一步观察冠脉夹层的进展。


Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis”介绍了PCB-Angioplasty治疗DES-ISR后复发再狭窄的OCT影像学发现,6个月后发生复发再狭窄病变处的组织异质性更高,再狭窄病变处的最小官腔、支架面积、支架膨胀程度等指标显著不足。


Long-term outcomes after treatment of bare-metal stent restenosis with paclitaxel-coated balloon catheters or everolimus-eluting stents: 3-year follow-up of the TIS clinical study”比较了3年PEB和DES在治疗BMS-ISR的长期疗效。


德国亚琛Schröder等回顾性完成了两种PCB术后一年MACE的比较分析“Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons采用单中心、非随机设计回顾性获取了单中心两种PCBs一年的MACE事概率(15.0 and 15.8% (P=0.879) for the BTHC-PCB and iopromide-based PCB groups)和1TLR、心梗、心源性死事件概率(分别为9.6 versus 11.8%, P=0.622; 5.3 versus 3.9%, P=0.640; and 5.3 versus 3.9%, P=0.640)。


Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 trial”比较了PCB两种药用辅料BTHC-PCB (n=127) iopromide-PCBn=137)置入6-8个月随访造影终点和1年临床终点。


Therapeutic efficacy of paclitaxel-coated balloon for de novo coronary lesions with diameters larger than 2.8 mm前瞻性地对以2.8mm为血管直径为分组阈值,在238例原发病变中评价紫杉醇涂层球囊的安全性和有效性。